Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Gounder MM, Razak AA, Somaiah N, Chawla S, Martin-Broto J, Grignani G, Schuetze SM, Vincenzi B, Wagner AJ, Chmielowski B, Jones RL, Riedel RF, Stacchiotti S, Loggers ET, Ganjoo KN, Le Cesne A, Italiano A, Garcia Del Muro X, Burgess M, Piperno-Neumann S, Ryan C, Mulcahy MF, Forscher C, Penel N, Okuno S, Elias A, Hartner L, Philip T, Alcindor T, Kasper B, Reichardt P, Lapeire L, Blay JY, Chevreau C, Valverde Morales CM, Schwartz GK, Chen JL, Deshpande H, Davis EJ, Nicholas G, Gröschel S, Hatcher H, Duffaud F, Herráez AC, Beveridge RD, Badalamenti G, Eriksson M, Meyer C, von Mehren M, Van Tine BA, Götze K, Mazzeo F, Yakobson A, Zick A, Lee A, Gonzalez AE, Napolitano A, Dickson MA, Michel D, Meng C, Li L, Liu J, Ben-Shahar O, Van Domelen DR, Walker CJ, Chang H, Landesman Y, Shah JJ, Shacham S, Kauffman MG, Attia S. Gounder MM, et al. Among authors: yakobson a. J Clin Oncol. 2022 Aug 1;40(22):2479-2490. doi: 10.1200/JCO.21.01829. Epub 2022 Apr 8. J Clin Oncol. 2022. PMID: 35394800 Free PMC article. Clinical Trial.
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Rouvinov K, Levanon E, Peer A, Sarfaty M, Sarid D, Neiman V, Grikshtas E, Rosenbaum E, Kushnir I, Talmor B, Friger M, Zarbiv Y, Gez E, Dresler H, Shalata W, Meirovitz A, Shrem NS, Yakobson A, Mermershtain W, Keizman D. Rouvinov K, et al. Among authors: yakobson a. Front Oncol. 2023 May 24;13:1151701. doi: 10.3389/fonc.2023.1151701. eCollection 2023. Front Oncol. 2023. PMID: 37293597 Free PMC article.
Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer.
Kian W, Christopoulos P, Remilah AA, Levison E, Dudnik E, Shalata W, Krayim B, Marei R, Yakobson A, Faehling M, Kahala D, Sara Granot I, Levitas D, Peled N, Roisman LC. Kian W, et al. Among authors: yakobson a. Front Oncol. 2022 Sep 20;12:1010311. doi: 10.3389/fonc.2022.1010311. eCollection 2022. Front Oncol. 2022. PMID: 36203432 Free PMC article.
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.
Hirsh-Yechezkel G, Chetrit A, Ben Avraham S, Agbarya A, Yakobson A, Asna N, Bar-Sela G, Ben-Aharon I, Ben-Baruch NE, Berger R, Brenner R, Gottfried M, Paluch-Shimon S, Pfeffer R, Popovtzer A, Ryvo L, Semenisty V, Shai A, Shulman K, Zidan J, Wolf I. Hirsh-Yechezkel G, et al. Among authors: yakobson a. Isr Med Assoc J. 2021 Dec;23(12):759-765. Isr Med Assoc J. 2021. PMID: 34954913 Free article.
42 results